Treatment Guidelines for Substance Use Disorder in Perinatal Patients
Treatment Guidelines for Substance Use Disorder in Perinatal Patients
Kyrah Coone
Virginia Commonwealth University
NURS 522
Professor Lyons
6/3/23
Substance Use Disorder in Perinatal Patients
Frazer, Z., McConnell, K., & Jansson, L. M. (2019). Treatment for substance use disorders in pregnant women: Motivators and barriers. Drug and alcohol dependence, 205, 107652.
Summary: Amidst pregnant women’s challenges when seeking treatment for substance use disorders, this article highlights the motivators and barriers that determine their decision. Personal motivation, social support, stigma, and access to appropriate care are key factors driving their need to enter and stay in a treatment program. The study offers a peek into the distinct challenges unique to these women and proposes solutions to enhance their treatment engagement.
Assessment/Evaluation: During pregnancy, the factors that drive and hinder people’s willingness to seek help for substance use disorders are explored in this article. The study employs a qualitative approach, utilizing interviews and focus groups with pregnant women who have experienced substance use disorders. This methodology allows in-depth exploration of participants’ perspectives and provides rich data to support the authors’ arguments. The article is published in a reputable journal, enhancing its credibility.
Reflection: Interventions and support systems targeting substance use disorders in pregnant women can be better informed by analyzing the factors influencing their decision-making process. This article provides valuable information on identifying these motivators and barriers, ultimately enhancing the comprehensiveness of such programs. This article’s findings can be utilized in a case study to assess the factors influencing treatment engagement and develop appropriate strategies to support perinatal patients with substance use disorders.
Gopman, S. (2014). Prenatal and postpartum care of women with substance use disorders. Obstetrics and Gynecology Clinics, 41(2), 213-228.
Summary: This piece aims to cognize readers about giving appropriate prenatal and postpartum medical attention to women with substance use disorders. This population requires comprehensive care while considering some specific factors, which can prove strenuous for caregivers. Important topics around standards for treating these patients are presented here, including screening tools employed for identifying issues early on or accessing timely interventions by professionals trained to assist them in every way possible. Examples like specialized psychiatric assistance or review procedures provide additional context throughout the article.
Assessment/Evaluation: This source provides treasured insight into prenatal and postpartum healthcare for women managing substance use difficulties. It encompasses various relevant topics while stressing the need for holistic, coordinated interventions customized toward addressing their exceptional necessities. Created by a learned professional from within this sphere and published through an esteemed channel fortifies its reliability further. Its contents come across as objective, concentrated chiefly on improving medical services delivered to individuals who are expecting while concurrently struggling with addiction-related conditions.
Reflection: This article provides valuable information for building comprehensive care plans for pregnant individuals dealing with substance abuse. It underscores the importance of accurately addressing challenges that emerge during the gestation and postpartum periods. By integrating suggestions articulated here into treatment protocols, healthcare providers can most effectively serve their patients’ unique needs during such a vulnerable time fully. Nevertheless, including additional sources featuring up-to-date research on emerging interventions could enhance our ability further to help those requiring more effective treatment.
Klaman, S. L., Isaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., & Jones, H. E. (2017). Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: Literature review to support national guidance. Journal of Addiction Medicine, 11(3), 178–190. https://doi.org/10.1097/ADM.0000000000000308
Summary: The prevalence of opioid use disorder (OUD) during pregnancy is increasing. Practical recommendations will help providers treat pregnant women with OUD and reduce potentially negative health consequences for the mother, fetus, and child. This comprehensive report explores the various challenges surrounding access faced by this group of women. It recommends women with OUD can be treated with methadone or buprenorphine during pregnancy. NAS is an expected and manageable condition. Although research has substantially advanced, opportunities to guide future research to improve maternal and infant outcomes are provided.
Assessment/Evaluation: This valuable source highlights the importance of critical components of patient support systems, given that women with OUD have a higher frequency of additional risk factors for adverse pregnancy outcomes than do pregnant women who do not use opioids, evidence-based clinical guidance on the treatment of these women and their children is needed.
Reflection: The present article, developed as part of a RAM process, serves as the basis for a series of recommendations for researchers and policymakers in the areas of OUD and pregnant women whose opioid exposure also exposed infants in utero. This work supports and extends the ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use, which includes guidance on treating pregnant women.
McLafferty, L. P., Becker, M., Dresner, N., Meltzer-Brody, S., Gopalan, P., Glance, J., … & Worley, L. L. (2016). Guidelines for the management of pregnant women with substance use disorders. Psychosomatics, 57(2), 115-130.
Summary: This article presents guidelines for addressing substance use disorders in pregnant women. The policies cover multiple care areas, such as screening, assessment, psychosocial interventions, pharmacotherapy, and postpartum care. Emphasis is placed on interdisciplinary approaches, provider cooperation, and personalized treatment strategies.
Assessment/Evaluation: Peer-reviewed, trustworthy, and timely, this source presents healthcare providers with detailed strategies for treating expectant mothers with substance use disorders. Full of expert-backed recommendations, it is comprehensive and unbiased – prioritizing what’s best for patients above all else. The publication’s credibility is further bolstered by its esteemed authors, leading authorities in the field. Ultimately, this guide serves as an invaluable resource for front-line healthcare professionals.
Reflection: Managing pregnant women with substance use disorders requires following the guidelines provided in a useful source. These will shape the approach to treatment and guarantee that evidence-based practices are carried out. Collaborative and individualized care is crucial for ideal results. Nevertheless, adding the latest research and recommendations for a well-rounded case study would be advantageous. More recent studies would supplement the current information.
Ramsey, K. S., Cunningham, C. O., Stancliff, S., Stevens, L. C., Hoffmann, C. J., Gonzalez, C. J., & Substance Use Guidelines Committee. (2021). Substance Use Disorder Treatment in Pregnant Adults.
Summary: Owing to its focus on providing evidence-based guidance regarding substance use disorder (SUD) treatment among pregnant adults, this publication is a crucial resource to healthcare providers within this field. The journal covers aspects related to care, such as screening processes, assessment methods, intervention approaches, pharmacotherapy programs, and psychosocial support services, while equally paying due attention to postpartum care.
Assessment/Evaluation: The guidelines presented here emphasize an all-embracing solution considering the unique situation of expectant mothers living under SUD conditions. These valuable insights are gleaned from professionals who are leaders within their industry; they include members whose publications were peer-reviewed on platforms like National Center for Biotechnology Information (NCBI).
Reflection: Implementation of these guidelines will aid in developing tailored case studies focused on pregnant patients living under SUD-laden conditions whose treatment will consist of evidence-based interventions delivered using patient-centered care supported at every juncture during pregnancy term baby delivery and into postpartum recovery stages critical for improved maternal health outcomes fetal wellness among other things.
References
Frazer, Z., McConnell, K., & Jansson, L. M. (2019). Treatment for substance use disorders in pregnant women: Motivators and barriers. Drug and alcohol dependence, 205, 107652.
Gopman, S. (2014). Prenatal and postpartum care of women with substance use disorders. Obstetrics and Gynecology Clinics, 41(2), 213-228. https://www.obgyn.theclinics.com/article/S0889-8545(14)00011-4/abstract
Klaman, S. L., Isaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., & Jones, H. E. (2017). Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: Literature review to support national guidance. Journal of Addiction Medicine, 11(3), 178–190. https://doi.org/10.1097/ADM.0000000000000308
McLafferty, L. P., Becker, M., Dresner, N., Meltzer-Brody, S., Gopalan, P., Glance, J., … & Worley, L. L. (2016). Guidelines for the management of pregnant women with substance use disorders. Psychosomatics, 57(2), 115-130. https://www.sciencedirect.com/science/article/pii/S0033318215002066
Ramsey, K. S., Cunningham, C. O., Stancliff, S., Stevens, L. C., Hoffmann, C. J., Gonzalez, C. J., & Substance Use Guidelines Committee. (2021). Substance Use Disorder Treatment in Pregnant Adults. https://www.ncbi.nlm.nih.gov/books/NBK572854/